We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test (10x20)
The GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test is intended for the qualitative detection of SARS-CoV-2 antigens from nasopharyngeal samples within 15 minutes.
The tests show diagnostic sensitivity of 92.6% and diagnostic specificity of 98.6%, therefore they meet the WHO performance criteria (sensitivity ≥ 80%; specificity ≥ 97%) for use in the global fight against COVID-19.
Related Products
The GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test is a double antibody-sandwich, qualitative membrane-based immunoassay. In-vitro diagnostic medical device. The kit is designed to detect nucleocapsid antigen from the SARS-CoV-2 in nasopharyngeal swabs from patients who are suspected of being COVID-19 positive.
Main Features
• Fast and reliable results in 15 minutes
• Sample material: nasopharyngeal swabs
• Cost-effective and easy to use; no additional special equipment required
• Transportation and storage at room temperature
• Diagnostic Sensitivity: 92.6% ; Diagnostic Specificity: 98.6%
• CE-IVD
Test Procedure
After sample collection, insert the swab into the tube containing the buffer solution. Rotate the swab for one
minute and close the lid. Use the dropper to transfer 3 drops (approximately 100 μL) of the specimen with
reagent to the specimen well (S) of the cassette, and start the timer.
| SKU | CVAG4940-10 |
|---|---|
| Test principle | Double antibody-sandwich, qualitative membrane-based immunoassay - In-vitro diagnostic medical device |
| Analysable samples | Nasopharyngeal swabs |
| Assay time | 15 min |
| No. of tests | 10x20 |
Test Instructions
-
IFU_GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test Size: (627.14 KB)
-
Brochure_GSD NovaGen SARS-CoV-2 (COVID-19) Antigen Rapid Test Size: (2.36 MB)